Weiqiang Cheng leads the Product Development Team in the Office of Technology Development as an Associate Director. He supports developing MSK’s internal pre-clinical pipeline products for IND submission. He joined OTD in May 2022.  

Weiqiang Cheng’s prior experience includes leading drug product development and supporting manufacturing and/or regulatory submissions of investigational and commercial drug products at Sanofi (Genzyme), Takeda (Shire) and Gilead. 

Weiqiang Cheng graduated from the National University of Singapore with a PhD in Pharmaceutical Sciences and University of Illinois Urbana-Champaign with an MBA.